Objectives: Adult dual kidney transplant is a strategy to overcome the imbalance between limited nephron mass supplied from an older donor and a recipient with a metabolic request. Materials and Methods: In our report, we review the literature and present our single-center experience. From June 2007 until July 2012, nine hundred twenty-eight single and seventeen dual kidney transplants from deceased donors were performed. Results: The average donor was 71.5 ± 3.6 years of age with an average serum creatinine, creatinine clearance, and an average number of sclerotic glomeruli, 106.1 ± 44.2 µmol/L, 0.97 ± 0.37 mL/s, and 22.4 ± 14.2. Immediate graft function and acute rejection episodes were observed in 75% and 6% of patients. The overall patient survival rates at 1 and 2 years after transplant were 93%. The overall graft survival rates at 1 and 2 years were 88%. Conclusions: Previous studies and our single-center experience suggest that the dual transplant procedure may help improve results of kidney transplants from expanded criteria donors and extend the donor pool by using kidneys that would be discarded otherwise.
Introduction
Earlier, we would reject organs from donors over 60 age years because of fear of diminished posttransplant function. 1 In 2002, extended criteria donors (ECDs) began to be used in clinical transplant. 2 However, the discard rate of these marginal donor organs was twice that of standard criteria donors (SCDs). 3 One strategy in overcoming the imbalance between the limited nephron mass (supplied from older donors) and the metabolic request of the recipient is dual kidney transplant (DKT). The first DKT was performed in the United States in 1996 by Johnson and associates. 4 We review the data and present our single-center experience with adult DKT. 14 HT/DM or proteinuria were comparable with SKT from < 3 g/24 h + Remuzzi ideal donors score 4 to 6
Andres and 2000 P, SC 21 15 ± 5 Age 60 to 74 y with 100% (12) 95% (12) PNF, AR were comparable with SKT, associates 17 GS 15% to 50%, age IF was significantly higher comparable ≥ 75 with GS < 50% with SKT   Bunnapradist  2003  R, MC  403  36 Kidneys not suitable ---62% (36) PNF was higher, DGF, AR was and associates 18 for SKT according UNOS comparable with SKT, and overall graft survival was lower, apart from DKT with donors over 55 y of age when graft survival was comparable with SKT. 7 However, subsequent analyses of these patients reveals that the recipients of DKTs from donors 54 to 60 years old had low serum creatinine levels up to 2 years after transplant and that may mean that these kidneys could have been used for an SKT. 8 Singh and associates 9 found that donors with an eGFR of 1.2 mL/s for a DKT was a better discriminator kidney transplant function than was an eGFR of 1.5 mL/s. In a recent prospective study, Snanoudj and associates 10 found that a donor eGFR between 0.5 and 1.0 mL/s was easily applicable to allocate ECD kidneys from donors over 65 years of age for a DKT. This finding also was confirmed by Timsit and associates, 11 in which kidneys with an eGFR of 0.5 to 1.0 mL/s from ECD donors were used for DKTs.
Current United Network for Organ Sharing (UNOS) guidelines 12 recommend considering DKTs if any 2 of the following criteria are present: donor age > 60 years old; an eGFR < 1.1 mL/s, rising serum creatinine at the time of recovery > 221 μmol/L); donor medical history (defined as either longstanding hypertension or diabetes mellitus); donor kidney histology (defined as moderate to severe glomerulosclerosis > 15% and < 50%). Another approach for using kidneys for a DKT is preimplantation biopsy results in an ECD. 13 In 1999, the International Panel of Pathologists suggested a biopsy-based scoring system for older kidneys with scores ranging from a minimum of 0 (no lesions) to a maximum of 12 (marked changes in vessels, glomeruli, tubules, and connective tissue). 14 Kidneys with a score of 3 or lower were recommended for single transplants, and scores between 4 and 6 were considered suitable for DKTs. Kidneys with a score of 7 or more were discarded. A prospective matched cohort study showed that kidneys from donors > 60 years of age were allocated to DKTs according to the Remuzzi histologic score providing they had the same graft function at 6 months as renal grafts did from ideal donors. 14 This result also was confirmed in another prospective study by Remuzzi with a longer follow-up. 15 In a recent retrospective study, Fernández-Lorente and associates 16 analyzed the effect of preimplantation histologic scores in SKTs and DKTs. Those authors confirmed that in SKTs, long-term graft survival was similar for histologic scores of 4 and ≤ 3, and in both cases, better than 5. Conversely, in DKTs, histologic scores of 4, 5, or 6 had no effect on graft survival. These results suggest that only scores of 5 and 6 should be allocated for DKTs.
The percentage of sclerotic glomeruli alone is a widely accepted parameter associated with poorer graft outcomes in SKTs and often used as a scoring parameter for DKTs. A group of Spanish authors 17 allocated kidneys for DKTs based on donor age over 75 years or, in donors aged 60-74 years with glomerulosclerosis between 15% and 50%. 17 In retrospective study of the UNOS data, graft with glomerulosclerosis over 20% had a similar 1-year graft survival in SKT and DKT patients. 18 A composite score, including clinical, perioperative, and histologic parameters, also is used for DKT selection. In a study by Dietl and associates, 19 scores based on donor age, serum creatinine, kidney weight, and degree of glomerulosclerosis was used to allocate kidneys for single or dual transplant. For each parameter, the score was 0 or 1 according to the values below or above a predefined cut-off level of 65 years for age, 159 μmol/L for serum creatinine, 30% for the degree of glomerulosclerosis, and 300 g both kidneys). The score of 1 or less resulted in an SKT, the score of 2 resulted in a DKT, and the score of > 2 resulted in refusal of the organs. At 1 year, such SKTs had similar graft survival but worse graft function when compared with dual transplant recipients. 19 Increasing use of pulsatile machine perfusion for ECD kidneys offered additional data that could be used for decision-making regarding kidney allocation. Stratta and associates 20 found that ECD kidneys with flow rates of > 80 mL/min and the resistance < 0.40 mm Hg/mL/min after a minimum of 6 hours on pulsatile perfusion were acceptable for DKTs. Data by Hugen and associates 21 in a study of 60 DKTs also showed that kidneys used for DKTs had lower final renal resistance compared with discarded kidneys.
Surgical technique of dual kidney transplant
Compared to SKTs, DKTs are more-demanding surgical procedures, resulting in longer surgical times and increased risk of surgical complications. 6 Both kidneys can be transplanted together in 1 (unilateral) or 2 (bilateral) separate iliac fossae through an extraperitoneal or a transperitoneal approach. 22 Many transplant centers perform DKTs using bilateral technique with 2 separate extraperitoneal incisions. Boggi and associates 23 showed a higher incidence of lymphoceles using unilateral graft placement compared with kidneys transplanted as separate grafts; also these grafts had a higher risk of hemorrhage with bilateral incisions. However, all previously described DKT techniques with standard vascular and ureteral anastomoses have been associated with significantly higher rates of early renal graft thrombosis, but similar rates of lymphocele, urinary tract fistula, and wound infection compared to SKTs. 17 In the study by Ekser and associates 24 with 100 unilateral DKTs, the authors reported surgical complication rates comparable to those of SKTs. On the other hand, in a recent study by Timsit and associates, 11 unilateral placement of both allografts was associated with an increased risk of single graft loss.
Immunosuppression protocol
Most groups recommend standard triple immunosuppression protocol with the use of a calcineurininhibitor. 6, 17 Cruzado and associates 25 analyzed 2 groups of patients who received either cyclosporinebased immunosuppression (cyclosporine, mycophenolate mofetil, and prednisolone) or calcineurin-inhibitor-free protocol (thymoglobulin induction, sirolimus, mycophenolate mofetil, and prednisolone), and did not find differences in graft function or survival using calcineurin-inhibitor-free immunosuppression. Another paper compared calcineurin-inhibitor-free with cyclosporine-based immunosuppression protocols and reported significantly lower rates of delayed graft function (DGF) and a lower rate of cytomegalovirus infection in the sirolimus group with no difference in creatinine at 1 year. 26 The incidence of acute rejection in DKT recipients was shown to be lower than it was in SKTs, 6, 12, 14 which suggests the possibility that increasing the antigenic load does not enhance immune response. 13 
Outcomes of dual kidney transplant
To date, many case reports, retrospective, and some prospective studies have analyzed early and long-term results of DKTs and have compared them to SKT outcomes. Table 1 describes the results of all prospective and large retrospective studies with at least 50 patients enrolled, studying patients after adult DKT. The publications were selected according to systematic review in PubMed database until 2012.
Materials and Methods: Our experience

Study design
For the purpose of our study, we retrospectively examined our database. In the time between June 2007 and July 2012, nine hundred twenty-eight single, and seventeen adult DKTs from deceased donors were performed. We analyzed the posttransplant outcomes (considering graft and patient survival rates, occurrence of DGF defined as the need for dialysis within the first week after transplant; acute rejection episodes [biopsy confirmed]; reoperation rate and cause; and serum creatinine at 1, 6 months, and 12 month after DKT). Grafts were considered "nonviable" in the following cases: graft nephrectomy, recipient's death, and return to dialysis. The loss of 1 graft out of 2 was classified as a "functioning kidney graft."
Indication criteria for dual kidney transplant
Kidneys from donors aged ˃ 65 years with eGFR < 1.1 mL/s or donors aged ˃ 65 years, with a history of hypertension or diabetes, were considered for DKT. During the retrieval, kidneys were examined macroscopically for scars and quality of vessels. After perfusion, a wedge biopsy of both kidneys was performed. Indications to use the kidneys for DKT/SKT or to discard them, was assessed based on the results of glomerulosclerosis together with the donor's clinical data. If glomerulosclerosis was more 20%, DKT was indicated. If glomerulosclerosis was more 50%, the kidneys were usually discarded. Although the Remuzzi criteria are not used for kidney selection in our transplant center, we evaluated them retrospectively.
Recipient criteria and surgical procedure
The recipient candidates for DKT in our center ≥ 60 years of age, with no previous kidney transplant, panel reactive antibody level < 20%, body mass index < 30, and had acceptable aortoiliac vessels and adequate dimensions of the abdomen, allowing placement of 2 renal grafts. Patients with general contraindications for renal transplant (ie, previous surgery on aortoiliac vessels, anticoagulant therapy, and large polycystic kidneys) were not considered for DKT. All protocols were approved by the ethics committee of the institution before the study began, and the protocols conformed with the ethical guidelines of the 1975 Helsinki Declaration. Written, informed consent was obtained from all patients enrolled into the DKT program. Kidney grafts were recovered using the standard multiorgan retrieval technique. Grafts were preserved separately under hypothermic conditions or using a hypothermic machine perfusion system (LifePort Kidney Transporter, Pulsatile Flow, Model LKT-100-P; Organ Recovery Systems, Itasca, IL USA). After bench surgery, 2 kidney grafts were implanted sequentially either bilaterally, using separate incisions, or unilaterally. A urethral stent was not used routinely, and it was left for the transplant surgeon's consideration.
clinical variables
We recorded the following donor parameters: age, sex, hypertension, diabetes mellitus, last serum creatinine and eGFR-MDRD CrCl (eGFR according to MDRD formula), type of preservation (hypothermic preservation or machine perfusion), cold ischemic time, and graft biopsy results (containing at least 10 glomeruli and at least 1 artery) including level of glomerulosclerosis (evaluated and expressed as the percentage value of global sclerotic glomeruli). Donors > 60 years of age or between 50 and 59 years of age, with at least 2 of the following 3 risk factors: death from stroke, pre-existing hypertension or chronic kidney disease with serum creatinine levels greater than 133 μmol/L were assigned as ECD. 27 Considered recipient parameters were: age, sex, time on the waiting list, number of human leukocyte antigen (HLA) mismatches, percentage of panel reactive antibodies at the time of transplant, and indication for a kidney transplant.
Immunosuppression
All patients received induction therapy with thymoglobulin; maintenance triple therapy included cyclosporine/tacrolimus, mycophenolate mofetil, and steroids. We try to reduce the possible calcineurin-inhibitor nephrotoxicity.
Statistical analyses
The data are expressed as mean values ± standard deviation, median (interquartile range) or frequencies (percentage). Graft and patient survival rates were assessed using the Kaplan-Meier method. Statistical analyses were performed with SPSS software (SPSS: An IBM Company, version 13.0, IBM Corporation, Armonk, NY, USA). Values for P < .05 were considered to be significant.
Results
Donor characteristics
The average donor age was 71.5 ± 3.6 years, with a female predominance of 12 (71%). Risk factors, hypertension, and diabetes were present in 16 patients (94%) and 5 patients (29%). Traumatic, cerebrovascular, and hypoxic cause of brain death among the donors for DKT occurred in 2 (12%), 13 (76%), and 2 patients (12%). The average serum creatinine and eGFR-MDRD CrCl of donors were 106.1 ± 44.2 μmol/L and 0.97 ± 0.37 mL/s. All donors were assigned as ECD. The average number of sclerotic glomeruli per sample was 22.4 ± 14.2, and the average Remuzzi score for both kidneys was 6.3 ± 1.1. Pulsatile machine perfusion was used in 3 donors (18%).
Recipient characteristics
The average recipient age was 65.9 ± 4.7 years, with a male predominance of 13 (77%). The recipient's kidney disease were diabetic nephropathy in 2 (12%), glomerulonephritis in 6 (35%), IgA nephropathy in 3 (18%), lupus nephritis in 1 (6%), nephrosclerosis in 1 (6%), polycytosis (6%), and tubulointerstitial nephritis in 3 patients (18%). The median time on the waiting list was 164 days (range, 108-390 d). The median number of HLA mismatches and pretransplant panel reactive antibodies were 3% (range, 2.5% to 4%) and 2% (range, 0% to 5%). Mean cold ischemic time was 18.1 ± 4.1 hours and bilateral technique of transplant was used in 16 recipients (94%).
Posttransplant outcome
The overall patient survival rates at 1 and 2 years after transplant were 93% for both. The overall graft survival rates at 1 and 2 years was 88% for both. Overall, 6 grafts in 3 patients were lost. Two patients underwent bilateral graft nephrectomy, 1 because of massive vascular thrombosis and 1, owing to multiorgan failure (who died 1 year later from cardiovascular disease). One patient lost both grafts, the first one on the seventh postoperative day because of a vascular complication, and the second one during fourth posttransplant year owing to infectious complications. This patient is still alive.
Patient and graft survival curves are shown in Figure 1 . Four patients had delayed graft function (25%) and 1 patient had an acute rejection episode (6%). Mean serum creatinine at the first and sixth month, and during the first and second years were 141 ± 44.2, 132 ± 26.5, 159 ± 26.5, and 186 ± 106.1 µmol/L. We observed posttransplant diabetes, pneumonia, and cardiovascular episodes in 2 (12%), 1 (6%), and 1 patient(s) (6%). Lymphocele and complex wound healing (ie, intestinal eventration) occurred in 2 (12%) and 1 patients (6%), while neoplastic complications were not observed. Ureteric complications were observed in 2 patients (12%), 1 requiring reoperation for ureteric necrosis, and 1 requiring temporary nephrostomy for ureteric stricture.
Discussion
The first prospective controlled multicentric trial, which was designed to compare outcomes of DKT versus SKT was published by Remuzzi and associates in 1999. 14 This study gave the fundamental knowledge for use of kidneys for a dual transplant, which would be otherwise discarded. Currently, a DKT is used as an option in many transplant centers. Dual kidney transplant gives us a chance to use kidneys from "marginal donors." Some prospective and retrospective studies (Table 1) compared DKT with transplant of single ECD kidneys. These studies found lower or similar DGF rates after a DKT. 12, 17, 18 Graft survival after a DKT compared with an SKT at 5 years (69% vs 61%) and 8 years (69.7% vs 59.4%) has been reported as comparable. 28, 29 Despite good DKT outcomes, decision-making remains the main dispute. The ongoing question is which kidneys should be used for single, and which for dual transplants, and which kidneys should be discarded. Despite the number of DKT selection parameters (see review part of this paper), there is no uniformity among transplant centers. 6 To date, there is only 1 prospective controlled study that evaluated allocation algorithm. In this study, Snanoudj and associates 10 used allocation criteria proposed by Remuzzi and associates. 14 Andres and associates 17 and UNOS criteria. 18 However, he did not find any improvement in 12-month eGFR of DKT compared with allocation based on donor eGFR. The only consensus found among centers is the basic of conditions for ECD, which are generally accepted as the starting point for further decision-making. Assessing of the functional status of ECD kidneys, the results of preimplantation biopsy and additional parameters during preservation together with transplant center experience remain an effective and safe strategy for DKT selection.
The first report of DKT in the Czech republic 30 was published by our team in 2008 and since the DKT program was nationally established. In this report, we retrospectively analyzed our own singlecenter experience of 17 recipients after DKT. Donors aged ˃ 65 years with eGFR < 1.1 mL/s or donors aged ˃ 65 years with a history of hypertension or diabetes were considered for DKT. After perfusion, wedge biopsy of both kidneys was performed and the final decision for accepting or discarding SKT/DKT was based on the assessment of all available parameters of the donor. The information obtained from pre-implantation biopsies in our institute focuses mainly on glomerulosclerosis.
Our selection criteria are similar to those used by UNOS. If any 2 of the following donor criteria exist (age ˃ 60 years; eGFR < 1.1 mL/s, sCr ˃ 221 μmol/L; presence of hypertension or diabetes with glomerulosclerosis between 15% and 50%), DKT is considered. In our study, the average donor age was 71.5 ± 3.6 years with average serum creatinine, creatinine clearance and average number of sclerotic glomeruli, 106.1 ± 44.2 μmol/L, 0.97 ± 0.37 mL/s, 1 and 22.4 ± 14.2. The Remuzzi score was retrospectively evaluated in 14 donors and for both kidneys the average score was 6.3 ± 1.1. Eight recipients had Remuzzi score in range 4-6. Such results proved to be acceptable for DKT by a prospective study. 14, 15 Conversely, 3 patients with the score of 7 also had good posttransplant outcomes, comparable with recipients with a score of 4 to 6. We also had 2 patients with Remuzzi score of 8, and 1 with a score of 9, in whom posttransplant function was lost during the early posttransplant period, as this scoring system predicts. Despite Remuzzi's approach for ECD kidney transplants was proved accurate in many prospective and retrospective studies, [14] [15] [16] [31] [32] [33] we cannot confirm this, probably because of the small number of patients in our study.
The early and intermediate results in our retrospective single-center study are comparable with many retrospective and some prospective studies (Table 1) . Immediate graft function and acute rejection episodes were observed in 75% and 6% of patients. These data are comparable with the largest DKT study published by Gill and associates, 12 where the occurrence of DGF and acute graft rejection were 29.3% and 5%. Overall graft survival at 2 years after transplant in our study was 88%, which is comparable with some studies. 10, 12, 21 The main limitation of this study is its retrospective fashion and small study group.
In conclusion, previous studies and our singlecenter experience suggest that the dual transplant procedures may activate improve the results of kidney transplants from ECDs and extend the donor pool by using kidneys that would otherwise be discarded. However, DKT does not, per se, guarantee the same outcomes as an SKT from a standard criteria donor.
